Respiratory Infections News

The Infectious Diseases Society of America and the HIV Medicine Association have issued policy recommendations to address the “alarmingly high rates” of COVID-19 in detention settings.

The CDC previously reported that about one-third antibiotic prescriptions in the United States are unnecessary. New data suggest that efforts to curb antibiotic overprescribing have taken a step backward during the COVID-19 pandemic, according to the Society for Healthcare Epidemiology of America.

Three New York children have died from a serious illness that may be related to COVID-19, Governor Andrew M. Cuomo announced. The illness has symptoms that resemble Kawasaki disease and toxic shock syndrome.

In response to the FDA’s recent emergency use authorization of remdesivir for the treatment of COVID-19, the Infectious Disease Society of America and the HIV Medicine Association, or HIVMA, called for public transparency from the federal government about the drug’s distribution.

Developers are using artificial intelligence to help researchers comb through thousands of studies and find relevant COVID-19 information for the development of potential treatments and vaccines.

Male gender, old age and the presence of underlying conditions appear to be the most common characteristics associated with fatal COVID-19 outcomes, according to results from a study of 14 patients published in Open Forum Infectious Diseases.

Accurate influenza diagnosis and vaccination could curtail unnecessary antibiotic use and help reduce the global threat of antibiotic resistance, according to findings in Clinical Infectious Diseases.

Accurate influenza diagnosis and vaccination could curtail unnecessary antibiotic use and help reduce the global threat of antibiotic resistance, according to findings in Clinical Infectious Diseases.

Older adults hospitalized with respiratory syncytial virus face costs that are similar to those of older adults hospitalized with influenza, according to findings published in The Journal of Infectious Diseases.

The FDA authorized the first COVID-19 diagnostic test using home-collected saliva specimens by issuing an emergency use authorization to Rutgers Clinical Genomics Laboratory, according to an FDA press release.